| Michelle Pappy, MD | |
|
10624 S Eastern Ave, Suite A263, Henderson, NV 89052-2982 | |
| (760) 628-5368 | |
| Not Available |
| Full Name | Michelle Pappy |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 12 Years |
| Location | 10624 S Eastern Ave, Henderson, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235490871 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 29388 (Oklahoma) | Primary |
| 207Q00000X | Family Medicine | 29388 (Oklahoma) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wickenburg Community Hospital | Wickenburg, AZ | Hospital |
| Entity Name | Riverview Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497204465 PECOS PAC ID: 1951689165 Enrollment ID: O20161022000158 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today introduced the latest version of its Regulatory Information Management (RIM) platform: LIQUENT InSight 6.0.
New research by Mimi E. Lam (University of Bergen) just published in Humanities and Social Sciences Communications identifies and explores the impacts of salient viral or COVID-19 behavioural identities that are emerging.
Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.
Theorem Clinical Research has announced the formation of a strategic alliance with Decision Driver Analytics that will integrate health economics and outcomes research (HEOR), predictive modeling and definitive analysis to maximize return on investment for pharmaceutical and medical device research programs.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Pappy, MD 10624 S Eastern Ave, Suite A263, Henderson, NV 89052-2982 Ph: () - | Michelle Pappy, MD 10624 S Eastern Ave, Suite A263, Henderson, NV 89052-2982 Ph: (760) 628-5368 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today introduced the latest version of its Regulatory Information Management (RIM) platform: LIQUENT InSight 6.0.
New research by Mimi E. Lam (University of Bergen) just published in Humanities and Social Sciences Communications identifies and explores the impacts of salient viral or COVID-19 behavioural identities that are emerging.
Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.
Theorem Clinical Research has announced the formation of a strategic alliance with Decision Driver Analytics that will integrate health economics and outcomes research (HEOR), predictive modeling and definitive analysis to maximize return on investment for pharmaceutical and medical device research programs.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
› Verified 3 days ago
Mihaela Florescu Missel, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 3001 Saint Rose Pkwy, Henderson, NV 89052 Phone: 702-616-5000 | |
Dr. Diana Dantian Lee, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10624 S Eastern Ave Ste A-955, Henderson, NV 89052 Phone: 702-407-7700 Fax: 702-407-7016 | |
Zachary David Hanson, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10624 S Eastern Ave # A-955, Henderson, NV 89052 Phone: 702-800-5393 | |
Mr. Neel Tapryal, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 10624 S Eastern Ave # A955, Henderson, NV 89052 Phone: 702-800-5393 | |
Dr. Sean Jeet Singh, M.D. Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 170 S Green Valley Pkwy Ste 300, Henderson, NV 89012 Phone: 702-794-1241 | |
Mr. Tabreez Shiraaz Ali, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 28 Brookridge Dr, Henderson, NV 89052 Phone: 702-487-7055 Fax: 702-991-7258 |